Proto: Dispatches from the Frontiers of Medicine
Love It or Hate It: Changing Evidence Regarding...04/29/10
Host: Bruce Bloom, DDS, JD Guest: Isaac Schiff, MD In the 80-year history of hormone therapy, it has been alternately embraced and rejected. Case in point: the original term, hormone replacementnbsp;therapy, came to be seen as highlighting a negative...
When the Drug Fits: Examining Targeted Cancer Therapy
Host: Bruce Bloom, DDS, JD Guest: David Fisher, MD, PhD Imatinib mesylate was initially approved for chronic myeloid leukemia. It has also been used against gastrointestinal cancer and melanoma. What are the implications of broadening the application...
- United States